Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Avissar, S. Articles by Schreiber, G. Search for Related Content PubMed Citation Articles by Avissar, S. Articles by Schreiber, G.

Dynamics of ECT Normalization of Low G Protein Function and Immunoreactivity in Mononuclear Leukocytes of Patients With Major Depression

OBJECTIVE: Heterotrimeric G proteins were previously implicated in the biochemical mechanisms underlying the pathophysiology and treatment of mood disorders. Low function and immunoreactivity of G proteins were observed in patients with major depression. In the present study the authors evaluated the effects of ECT on the low measures of G proteins in patients with major depression. METHOD: Repeated G protein measurements in mononuclear leukocytes of 10 patients with major depression were made. Each patient was examined while untreated and after successive sessions of ECT; 14 normal subjects were also studied. G protein function was evaluated through ß-adrenergic- and muscarinic-agonist-enhanced guanine nucleotide binding capacity, substantiated by quantitative measures of G proteins through immunoblot analyses using polyclonal antibodies against G_s, G_i, and Gß proteins. RESULTS: Mononuclear leukocytes of patients with depression showed immunoreactive levels of G_s and G_i that were significantly lower than those of normal subjects; the depressed patients also had markedly hypofunctional G_s and G_i. The low levels of G protein function and immunoreactivity were alleviated by ECT. Repeated measurements in the same patients after successive ECT sessions showed that the normalization of G protein measures preceded, and thus predicted, clinical improvement. The function and quantity of G_s and G_i proteins in patients given ECT were significantly correlated. CONCLUSIONS: These findings support the implication of G proteins in the pathophysiology and treatment of mood disorders. G protein measurements in patients with depression may potentially serve not only as a biochemical marker for affective state but also for biochemical prediction and evaluation of responses to ECT.

This article has been cited by other articles:

				S. Avissar, A. Matuzany-Ruban, K. Tzukert, and G. Schreiber {beta}-Arrestin-1 Levels: Reduced in Leukocytes of Patients With Depression and Elevated by Antidepressants in Rat Brain Am J Psychiatry, November 1, 2004; 161(11): 2066 - 2072. [Abstract] [Full Text] [PDF]

				G. Chen, K. A. Hasanat, J. M. Bebchuk, G. J. Moore, D. Glitz, and H. K. Manji Regulation of Signal Transduction Pathways and Gene Expression by Mood Stabilizers and Antidepressants Psychosom Med, September 1, 1999; 61(5): 599 - 617. [Abstract] [Full Text] [PDF]

				S. Avissar, G. Schreiber, Y. Nechamkin, I. Neuhaus, G. K. Lam, P. Schwartz, E. Turner, J. Matthews, S. Naim, and N. E. Rosenthal The Effects of Seasons and Light Therapy on G Protein Levels in Mononuclear Leukocytes of Patients With Seasonal Affective Disorder Arch Gen Psychiatry, February 1, 1999; 56(2): 178 - 183. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us